Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection of the NIPRO LVAD cannula site after implantation of an extracorporeal VAD was controlled by treatment with crystal violet Solbase (Nihon University crystal violet method).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2015.04.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Appropriate Use and Care of Peripheral Intravenous Cannulas: A Quality Improvement Project.
Cureus
January 2025
Diabetes and Endocrinology, Peterborough City Hospital, Peterborough, GBR.
Article Synopsis
- More than a third of peripheral intravenous cannulas (PIVCs) inserted in hospitals remain unused, highlighting issues with documentation and potential complications.
- A quality improvement project involved conducting an initial audit, implementing changes, and a follow-up audit to assess adherence to a PIVC care bundle.
- The project aimed for a target adherence score of 90-100% on PIVC documentation and care; results showed a comparison between the first and second cycles, with improved scores indicating successful implementation.
Unfractionated heparin monitoring by anti-factor Xa versus activated partial thromboplastin time strategies during venoarterial extracorporeal life support.
Perfusion
December 2024
Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Introduction: No clear guidelines exist for unfractionated heparin (UFH) monitoring in adult patients on veno-arterial extracorporeal life support (VA-ECLS) for refractory cardiogenic shock. In this study, we sought to compare outcomes between anti-factor Xa (FXa) and activated partial thromboplastin time (aPTT) strategies for UFH monitoring during VA-ECLS.
Methods: This is a single-center, retrospective review of VA-ECLS patients who received UFH in the cardiothoracic intensive care unit between July 2019 and November 2023.
Percutaneous circulatory assistance in an interventional cardiology centre without on-site cardiac surgery.
Arch Cardiovasc Dis
December 2024
Department of Cardiology, Bastia Hospital Centre, 20604 Bastia, France.
Background: Percutaneous extracorporeal membrane oxygenation (ECMO) has been developed thanks to the progress in the field of cannulation, but still justifies the presence of an on-site cardiac resuscitation department. Corsica is a French island without an on-site cardiac surgery department.
Aim: To evaluate the percutaneous ECMO programme in Corsica.
Proof of concept testing of a vascular closure device for use in fetal surgery.
J Matern Fetal Neonatal Med
December 2025
University of Cincinnati Medical College of Medicine, Cincinnati, OH, USA.
Objective: Prior clinical findings have demonstrated that maternal laparotomy with trans-amniotic trans-uterine suturing of the fetoscopic port site during in utero myelomeningocele repair reduces the risk of membrane rupture. However, due to laparotomy-associated morbidity, we aimed to explore the feasibility of using a vascular closure device for percutaneous trans-amniotic trans-uterine suturing.
Methods: This IRB and IACUC-exempt study utilized 2 strategies for proof-of-concept testing of using the Abbott Perclose ProStyle Device for suture placement; 1.
Does the Type of Cannula Matter? A Case Report and Review of the Evidence Regarding Steel and Plastic Cannulae With Respect to a Continuous Subcutaneous Insulin Infusion.
Cureus
November 2024
Endocrinology, Jefferson Einstein Philadelphia Hospital, Philadelphia, USA.
A new paradigm in the management of diabetes mellitus evolved following the introduction of continuous subcutaneous insulin infusions (CSII) into clinical practice. Outcomes include greater patient satisfaction alongside improved glycemic control. Drawbacks, however, which cannot be omitted, include patient, technology, and both patient and provider error.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!